Form 4: Biogen Director Stephen Sherwin Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Director Stephen Sherwin reported the acquisition and disposal of Biogen (BIIB) common stock on June 21, 2024.
Summary
- On June 21, 2024, Stephen Sherwin, a director of Biogen Inc. (BIIB), reported changes in his beneficial ownership of the company's common stock.
- Sherwin acquired 1,340 shares of common stock.
- He also disposed of an unspecified amount of common stock.
- Following the reported transactions, Sherwin beneficially owns 20,078 shares of Biogen common stock.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing. The sentiment is neutral as it simply reports transactions.
Industry Context
Form 4 filings are standard disclosures required by the SEC when corporate insiders (officers, directors, and large shareholders) buy or sell their company's stock. These filings provide transparency into insider transactions and can be used by investors to gauge sentiment.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 06/21/2024 | Date of the stock transaction (acquisition and disposal). |
| 06/25/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.